Zhejiang Charioteer Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ACYCLOVIR USP (API), with a corresponding US DMF Number 20203.
Remarkably, this DMF maintains an Active status since its submission on January 12, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 07, 2013, and payment made on February 21, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II